Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02400502 · ClinicalTrials.gov registry record · NA

Integrated Coping and Awareness Training

A NA study of Schizophrenia, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT02400502 is a NA study of Schizophrenia that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 6 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02400502, a NA study of Schizophrenia, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

Integrated Coping and Awareness Therapy is a novel therapeutic intervention combining strategies to improve stress reactivity and increase meaningful coping, as well as a range of possible proximal (e.g. immune indices of stress reactivity, symptom severity) and distal measures (e.g. relapse, quality of life).

Conditions Studied

Interventions

  • BEHAVIORAL I-CAT Therapy

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2015-03
Est. Completion 2016-04
Phase NA

What the Registry Record Tells You About NCT02400502

The ClinicalTrials.gov registry entry for NCT02400502 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (97% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which I-CAT Therapy is the first listed.

NCT02400502 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02400502 about?

NCT02400502 is a clinical study titled "Integrated Coping and Awareness Training". Integrated Coping and Awareness Therapy is a novel therapeutic intervention combining strategies to improve stress reactivity and increase meaningful coping, as well as a range of possible proximal (e.g. immune indices of stress reactivity, symptom severity) and distal measures (e.g. relapse, qualit...

What is the current status of trial NCT02400502?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2015-03. Estimated completion is 2016-04.

What conditions does trial NCT02400502 study?

This clinical trial studies the following conditions: Schizophrenia.

What interventions are being tested in trial NCT02400502?

The interventions under investigation include: I-CAT Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT02400502?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02400502 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.